do glp 1 reduce alcohol cravings GLP-1 medications: The next big thing in use disorder treatment? – Recovery Research Institute Results of a placebo-controlled trial

Curcumin administration and the effects on psychological status and markers of inflammation and oxidative damage in patients with type 2 diabetes and coronary heart disease

Insulin resistance and chronic hyperglycemia cause a cascade of pathological events in the brain, including neuroinflammation, impaired neurotransmitter systems and energy metabolism, oxidative stress, and vascular pathologies that ultimately lead to neurodegeneration, loss of synaptic plasticity, brain aging, cognitive impairment, and dementia

Cominato L, Resende ML, Bernardes N, Rachid LL, Passone CGB, Mattar LBF et al

We further differentiate the skeletal effects of disease-associated versus intervention-induced weight loss, with a focus on their distinct molecular underpinnings

Tirzepatide slows gastric emptying, possibly altering the absorption of some drugs

In each case, a provider should confirm a deficiency before starting treatment